Preclinical studies showed that PARP1 can interact with ERG, and inhibition of PARP1 enhanced DNA double-strand breaks induced by ERG overexpression and slowed the growth of ERG-positive prostate cancer cells [35]. The gene discussed is ERG; the disease is prostate carcinoma.